Antibiotic use and antimicrobial resistance remain stable Antibiotic resistance in the Netherlands remained stable in 2021 compared with the five previous years. This is evident from the 2022 annual NethMap/MARAN report.
Can healthy gut microbes protect us against antibiotic-resistant bacteria? It is largely assumed within the scientific community that a healthy intestinal microbiome can provide resistance against the settling, growth and multiplication of antibiotic-resistant bacteria.
Seasonal flu epidemic in the Netherlands The flu epidemic in the Netherlands has started. The number of people with flu (influenza) increased significantly in the past two weeks.
Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
New WHO Collaborating Centre hosted by RIVM combines laboratory preparedness and biorisk RIVM has been designated WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk by the World Health Organization (WHO).
Zoonoses Report 2020 focuses on emerging zoonoses The COVID-19 pandemic and the outbreak of the West Nile Virus in 2020 show that so-called emerging zoonoses pose a risk to the Netherlands. ANP
European project COHESIVE develops sustainable One Health approaches Today, fellow scientists and policymakers join the end symposium of the international project COHESIVE: One Health Structures in Europe.
Sewage treatment workers not more likely to carry antibiotic-resistant bacteria Employees at sewage and wastewater treatment plants in the Netherlands and Germany are not more likely to carry antibiotic-resistant bacteria than other people. Unie van Waterschappen
Vaccination coverage increases for second consecutive year, by 10% for HPV The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons